U.S. health regulators rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the market, but for the first time required patient notification about reports of suicidal behavior in men taking the drug.
By Dan Levine (Reuters) - U.S. health regulators rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the ma.
Lawsuit Brings Renewed Attention to Finasteride Adverse Events medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.